Myelodysplastic Syndromes
About
Mappings
NCI Thesaurus: Myelodysplastic Syndrome (coding:ncit:C3247)
OncoTree: Myelodysplastic Syndromes (coding:oncotree:MDS)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) FDA (2) | PDGFRA rearrangements | Myelodysplastic Syndromes | Imatinib | |
| EMA (1) FDA (2) | PDGFRB rearrangements | Myelodysplastic Syndromes | Imatinib | |
| FDA (2) | IDH1 p.R132C | Myelodysplastic Syndromes | Ivosidenib | |
| FDA (2) | IDH1 p.R132G | Myelodysplastic Syndromes | Ivosidenib | |
| FDA (2) | IDH1 p.R132H | Myelodysplastic Syndromes | Ivosidenib | |
| FDA (2) | IDH1 p.R132L | Myelodysplastic Syndromes | Ivosidenib | |
| FDA (2) | IDH1 p.R132S | Myelodysplastic Syndromes | Ivosidenib | |
| FDA (2) | 5q deletion | Myelodysplastic Syndromes | Lenalidomide |